key: cord-0694714-yrxo7nw0
authors: Cercy, S. P.
title: Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort
date: 2020-05-26
journal: nan
DOI: 10.1101/2020.05.23.20099671
sha: a8cc76e3f35cec0ab05d425980791c0cd8d02c36
doc_id: 694714
cord_uid: yrxo7nw0

Several medical risk factors for COVID-19 have been identified. However, additional factors likely account for some of the observed variability in COVID-19 outcomes. We examined the relationships between chronic psychiatric disorders and COVID-19 morbidity and mortality. Medical records from a cohort of 141 skilled nursing facility residents were reviewed. Multivariate logistic regression modeling determined psychiatric predictors for hospital admission, intensive care unit (ICU) admission, and mortality after controlling for medical risk factors. After controlling for all medical risk, altered mental status (AMS) was a predictor of hospital admission (p = .005), ICU admission (p = .015), and mortality (p = .006). Anxiety (p = .008) and dementia (p = .040) were also associated with an elevated risk of death. A simplified model yielded comparable findings. AMS was associated with a greater risk of hospital admission (p = .002), ICU admission (p = .024), and mortality (p = .006); anxiety (p = .002) was also a powerful predictor of mortality. After accounting for medical risk, morbidity and mortality due to COVID-19 are higher than expected in patients with chronic anxiety disorders, dementia, and AMS. Mechanisms underlying adverse outcomes remain to be determined. Links to neuroendocrine modulation, inflammation, and immune functioning are considered. Furthermore, outcomes in patients with dementia and AMS suggest COVID-19 poses substantial risk to the brain.

. Clearly, however, additional factors remain to be identified which account for some of the observed variability in COVID-19 outcomes. For example, a surprising number of deaths has occurred among apparently healthy young people for reasons yet to be understood. Early evidence (2) which was subsequently replicated suggests blood type may play a role in COVID-19 outcomes, with type O being protective, versus type A being a risk-conferring state (3) . A subset of COVID-19 patients have presented with diffuse clotting (4), resulting in stroke and other coagulopathy syndromes.

Chronic psychiatric disorders may represent one set of factors deserving consideration as a potential contributor to the variability of COVID-19 outcomes. To that end, we examined medical records in a cohort of skilled nursing facility residents to determine whether psychiatric disorders represent one such group of contributing factors.

We collected data from the Veterans Administration (VA) Computerized Patient Record System (CPRS) for a cohort of Community Living Center (CLC) residents (N = 141) during the study period from 1st March through 10th May 2020. New admissions for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.23.20099671 doi: medRxiv preprint 4 unrelated to COVID-19 were excluded. One COVID-positive resident died from causes not related to COVID-19, and so was excluded from multivariate analyses of the endpoint mortality to avoid that confound.

SARS-CoV-2 RNA was confirmed via polymerase chain reaction. Data for five chronic medical conditions-HTN, DM, COPD, CKD, and CVD-were collated. The latter excluded atrial fibrillation (AF); early evidence suggests anticoagulant agents commonly used for managing AF appear to provide some protection (5) against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Psychiatric diagnostic categories were organized into the following groups. Chronic disorders included six conditions. Depressive disorders included all specified and unspecified depressive disorders, and adjustment disorders with a component of depression; the same conceptualization was applied to anxiety disorders. Posttraumatic stress Disorder (PTSD) and bipolar disorder (BAD) were each considered as its own entity. Schizophrenia was inclusive of schizoaffective disorder of any type.

Dementia included all subtypes and unspecified diagnoses. One acute psychiatric diagnostic condition considered was alteration of mental status (AMS), which was determined by: 1) documentation of the phrase AMS in CPRS, or; 2) CPRS keyword search for the terms "confusion", "confused", "alteration", and "altered". AMS was deemed present if the search term either occurred in the absence of a diagnosis of dementia, or in the event of a dementia diagnosis, represented a clear departure from baseline mental status.

for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Demographic and clinical characteristics of the CLC cohort are given in Table 1 . The mean age (years) was 75.4 (SD = 11.5). Residents were heterogeneous with respect to race (44.0% Black) and ethnicity (10.6% Hispanic). Females comprised 2.8% of the cohort, which is representative of veterans populations. The prevalence of COVID-19 among the cohort was 67.4%. Of 81 confirmed COVID-positive cases, 24 (29.6%) were admitted to hospital, and 10 (12.3%) required ICU admission. Fourteen residents died due to COVID-19 during the 71-day study period, for a mortality rate of 17.3%. We found no relationships between any endpoint and age (absolute value of all < .065, all p > .40), race (all 2 < 0.48, p > .23) , or ethnicity (all 2 < 3.47, p > .061). Therefore, those variables excluded from subsequent analyses.

for use under a CC0 license.

This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Outcomes for medical and psychiatric factors by endpoint are shown in Table 2 . In a model with 12 predictor variables, medical factors were entered in block one, followed by psychiatric factors in block two (model R 2 = .33; 2 = 31.76, p = .002). After controlling for medical risk, AMS (p = .005) was a significant predictor of hospital admission. COPD (p = .013) was the one medical factor predicting admission. AMS (p = .015) along with CVD (p = .023) and COPD (p= .009) were predictors of ICU admission (model R 2 = .53; 2 = 35.45, p < .001). With respect to the mortality endpoint (model R 2 = .46; 2 = 36.25, p < .001), anxiety (p = .008), dementia (p = .040), and AMS (p = .006) were all associated with an elevated risk of death.

From the findings above, we considered a simplified model using the best predictors identified in the full model: COPD, CKD, anxiety, dementia and AMS. In this model, AMS was a predictor of all outcomes. Patients with AMS were at greater risk of hospital admission (OR 4.52, 95%CI 1.75-11.65, p = .002), which was comparable to COPD (OR 5.01, 95%CI 1.79-14.04, p = .002). AMS was also associated with a higher risk of ICU This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This study may be the first to report that psychiatric disease may contribute to adverse outcomes in patients with COVID-19. We demonstrate that after accounting for medical risk, morbidity and mortality due to COVID-19 are higher than expected among individuals with chronic anxiety disorders, dementia, and AMS.

Mechanisms mediating these outcomes in chronic psychiatric disorders remain to be determined. Pathogenesis caused by SARS-CoV-2 appears to involve intricate interrelationships involving the inflammatory response (6) and immune system functioning (7,8), localized particularly within the vascular endothelium (9), which in turn promotes clotting. In addition to its involvement in a wide range medical disease, inflammation, via links to chronic stress and neuroendocrine modulation, plays a central feature in psychiatric disease as well, including but not limited to anxiety disorders (10), depression (11,12), bipolar disorder (13) and schizophrenia (14) . Psychiatric patients who are advanced in age may be particularly at risk for inflammatory changes (10,12).

According to the CDC, "new confusion," along with dyspnea and cyanosis, has been classified as an "emergency warning sign" indicating a need to seek immediate medical attention (15) . This study shows for the first time that COVID-19 patients presenting with AMS appear to be highly vulnerable to adverse outcomes. Several possibilities may account for this finding. First, cerebral function may be perturbed as a secondary consequence of involvement of other organ systems. Delirium is a frequent sequel of dysfunction of the heart, lungs, or kidneys (16), any of which has been shown to be compromised in COVID-19 (17). Second, given recent findings implicating coagulopathy for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.23.20099671 doi: medRxiv preprint as an important consequence in a subset of COVID-19 patients (4), the cerebral vasculature is likely to be vulnerable to the same pathophysiological process observed in other organ systems.

Third, the possibility that SARS-CoV-2 is capable of directly infecting central nervous system (CNS) neurons must be considered (18) . Angiotensin converting enzyme-2 (ACE-2) receptors are ubiquitously distributed in the body, and are the means by which SARS-CoV-2 particles gain access to cells of multiple organ systems, including lung, heart, gut, kidneys-and brain (19) . Thus, it is conceivable that direct infection of CNS neurons accounts for AMS observed in COVID-19 patients, and that AMS reflects a potentially critical state in which the risk of death is substantially heightened. A corollary to evidence of CNS vulnerability involves the olfactory bulb, which is one of only two projections of CNS tissue into the periphery (20) . The observation that anosmia is a common early-stage symptom of COVID-19 (15) is consistent with CNS vulnerability to infection by SARS-CoV-2.

A strength of this study is the homogeneity of medical care provided to all CLC residents regardless of demographic factors; this stands in stark contrast with reports of racial and ethnic disparities in COVD-19 outcomes found in other facilities across the United States (21) . The main limitation of this study is its relatively limited sample size.

Nonetheless, the study cohort is entirely representative of the population within CLC at the time of the COVID-19 outbreak. Additional studies are needed to replicate and extend these findings in larger populations.

for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This study may provide a window onto the influence of psychiatric disturbance in this highly consequential novel viral disease. Clinicians should be cognizant not only of their patients' medical risk for complicated COVID-19 outcomes, but of the potential contribution of chronic psychiatric disorders as well.

for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.23.20099671 doi: medRxiv preprint

Characteristics of and Important Lessons From the

COVID-19) Outbreak in China: Summary of a Report of

Cases From the Chinese Center for Disease Control and Prevention

Relationship between the ABO Blood Group and the COVID-19 Susceptibility

Association between ABO blood groups and risk of SARS-CoV-2 pneumonia

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19

Chronic Systemic Inflammation Is Associated with Symptoms of Late-Life Depression: The ARIC Study

A High Prevalence of Organ-Specific Autoimmunity in Patients with Bipolar Disorder

Elevated Interleukin-2, Interleukin-6 and Interleukin-8 Serum Levels in Neuroleptic-Free Schizophrenia: Association with Psychopathology

Coronavirus Disease 2019 (COVID-19), Symptoms of Coronavirus [CDC COVID-19 web site

Delirium in older persons

It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

COVID-19 and Multi-Organ Response. Curr ProbCardiology 2020 in press

Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

The Olfactory System and Its Disorders

COVID-19 and African Americans

It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Dr. Cercy is solely responsible for all aspects of this study.

The author has no conflicts of interest to disclose.for use under a CC0 license.This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.